Fig. 3From: Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbaginCYP1A2 and 3A11mRNA expression levels in mouse liver cells treated with 6.25, 12.5 and 25Â mg/kg body weight for 28Â days of plumbagin) and control groups. GAPDH was used as an internal control. CYP1A2 and 3A11mRNA expression levels were quantified by RT-PCR analysis in relation to GAPDH. Data are expressed as median (interquartile range) from 3 male miceBack to article page